Search
Now showing items 1-10 of 13
Analyzing implementation dynamics using theory-driven evaluation principles: lessons learnt from a South African centralized chronic dispensing model
(BioMed Central, 2017)
BACKGROUND: Centralized dispensing of essential medicines is one of South Africa’s strategies to address the shortage of
pharmacists, reduce patients’ waiting times and reduce over-crowding at public sector healthcare ...
Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study
(Public Library of Science, 2018)
In Kenya, noncommunicable diseases (NCDs) account for 27% of all deaths. Adult Kenyans
have an 18% chance of dying prematurely from cancers, diabetes, cardiovascular diseases
or chronic respiratory diseases. A Novartis ...
Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases
(Public Library of Science, 2017)
BACKGROUND:
WHO has set a voluntary target of 80% availability of affordable essential medicines, including
generics, to treat major non-communicable diseases (NCDs), in the public and private
sectors of countries by ...
Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya
(BMJ Publishing Group, 2016)
INTRODUCTION: Novartis recently launched Novartis
Access, an initiative to provide a basket of reduced
price medicines for non-communicable diseases
(NCDs) to be sold through the public and private nonprofit
sectors ...
Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania
(BioMed Central Ltd., 2017)
Background: To assess the effect of policies supporting local medicine production to improve access to medicines. Methods: We adapted the WHO/HAI instruments measuring medicines availability and prices to differentiate ...
Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases
(Public Library of Science, 2017)
Background: WHO has set a voluntary target of 80% availability of affordable essential medicines, including generics, to treat major non-communicable diseases (NCDs), in the public and private sectors of countries by 2025. ...
The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP)
(Elsevier, 2020)
The Glivec International Patient Assistance Program (GIPAP) is a unique direct-to-patient program that provides imatinib (Glivec) at no cost to eligible patients in low- and middle-income countries (LMICs) with chronic ...
Probability and amount of medicines expenditure according to health insurance status in Kenya: A household survey in eight counties
(Wiley, 2021)
National and county governments in Kenya
have introduced various health insurance schemes to protect households against financial hardship as a result of large
health expenditure. This study examines the relationship
between ...
Program sustainability post PEPFAR direct service support in the Western Cape, South Africa
(Public Library of Science, 2021)
Public health practitioners have little guidance around how to plan for the sustainability of
donor sponsored programs after the donor withdraws. The literature is broad and provides
no consensus on a definition of ...
Management of type 1 diabetes in low- and middle- income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania
(Wiley, 2022)
To describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, Peru and Tanzania. The Rapid Assessment Protocol for Insulin Access, a multi- level assessment of the health system, was implemented ...